Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PERRIGO Co plcPRGO · Entity 4516 | EVP, Chief Medical Officer | April 05, 2024 | April 09, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PERRIGO Co plc
Report date April 05, 2024 · Filed April 09, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 6,210 |
Reported balance
After 2024-04-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-04-05 · Grant · Acquired 6,210 · Balance 6,210 F1: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 April 2025. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 21,078 |
Reported balance
Holding disclosure · report date 2024-04-05 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 21,078 |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.
F2: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 April 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 05, 2024 Filed Apr 9, 2024 21:24 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantRestricted Stock Units · Derivative | 6,210 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-24-000061 · wk-form4_1712697890.xml · derivative · entry 2 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,210 Underlying: Ordinary Shares · 6,210 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 April 2025. F2 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 April 2025. Read SEC document |
| March 07, 2024 Filed Mar 9, 2024 02:57 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionRestricted Stock Units · Derivative | 2,249 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-24-000043 · wk-form4_1709953062.xml · derivative · entry 6 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,249 Underlying: Ordinary Shares · 2,249 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F3 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 7 March 2023. F3 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 7 March 2023. Read SEC document |
| March 07, 2024 Filed Mar 9, 2024 02:57 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 1,170 | $29.69 | $34,737.30 |
DisclosureSEC source: 0001585364-24-000043 · wk-form4_1709953062.xml · nonDerivative · entry 4 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,078 Read SEC document |
| March 07, 2024 Filed Mar 9, 2024 02:57 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionOrdinary Shares | 2,249 | $29.69 | $66,772.81 |
DisclosureSEC source: 0001585364-24-000043 · wk-form4_1709953062.xml · nonDerivative · entry 3 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,248 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2024 Filed Mar 9, 2024 02:57 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionRestricted Stock Units · Derivative | 1,759 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-24-000043 · wk-form4_1709953062.xml · derivative · entry 5 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,517 Underlying: Ordinary Shares · 1,759 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 6 March 2024. F2 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 6 March 2024. Read SEC document |
| March 06, 2024 Filed Mar 9, 2024 02:57 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 915 | $28.09 | $25,702.35 |
DisclosureSEC source: 0001585364-24-000043 · wk-form4_1709953062.xml · nonDerivative · entry 2 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,999 Read SEC document |
| March 06, 2024 Filed Mar 9, 2024 02:57 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionOrdinary Shares | 1,759 | $28.09 | $49,410.31 |
DisclosureSEC source: 0001585364-24-000043 · wk-form4_1709953062.xml · nonDerivative · entry 1 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2024 Filed Mar 8, 2024 02:00 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionRestricted Stock Units · Derivative | 1,583 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-24-000021 · wk-form4_1709863230.xml · derivative · entry 5 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,583 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. F2 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. Read SEC document |
| March 05, 2024 Filed Mar 8, 2024 02:00 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 4,695 | $27.26 | $127,985.70 |
DisclosureSEC source: 0001585364-24-000021 · wk-form4_1709863230.xml · nonDerivative · entry 4 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,155 Read SEC document |
| March 05, 2024 Filed Mar 8, 2024 02:00 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantOrdinary Shares | 9,028 | $27.26 | $246,103.28 |
DisclosureSEC source: 0001585364-24-000021 · wk-form4_1709863230.xml · nonDerivative · entry 3 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,850 Read SEC document |
| March 05, 2024 Filed Mar 8, 2024 02:00 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 824 | $27.26 | $22,462.24 |
DisclosureSEC source: 0001585364-24-000021 · wk-form4_1709863230.xml · nonDerivative · entry 2 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,822 Read SEC document |
| March 05, 2024 Filed Mar 8, 2024 02:00 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionOrdinary Shares | 1,583 | $27.26 | $43,152.58 |
DisclosureSEC source: 0001585364-24-000021 · wk-form4_1709863230.xml · nonDerivative · entry 1 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:55 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionRestricted Stock Units · Derivative | 2,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-23-000031 · wf-form4_167831251103976.xml · derivative · entry 3 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,498 Underlying: Ordinary Shares · 2,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F1 · kind: Vesting of service-based restricted stock units granted on 7 March 2022. F2 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F3 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 7 March 2023. F3 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 7 March 2023. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:55 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 1,170 | $37.71 | $44,120.70 |
DisclosureSEC source: 0001585364-23-000031 · wf-form4_167831251103976.xml · nonDerivative · entry 2 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,063 Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:55 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionOrdinary Shares | 2,250 | $37.71 | $84,847.50 |
DisclosureSEC source: 0001585364-23-000031 · wf-form4_167831251103976.xml · nonDerivative · entry 1 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of service-based restricted stock units granted on 7 March 2022. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:55 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantRestricted Stock Units · Derivative | 5,276 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-23-000031 · wf-form4_167831251103976.xml · derivative · entry 4 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,276 Underlying: Ordinary Shares · 5,276 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F4 · kind: Grant of service-based restricted stock units granted on 6 March 2023. F2 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F5 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 6 March 2024. F5 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 6 March 2024. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 20:24 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionRestricted Stock Units · Derivative | 1,584 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-23-000011 · wf-form4_167822065494330.xml · derivative · entry 8 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,583 Underlying: Ordinary Shares · 1,584 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F3 · kind: Vesting of service-based restricted stock units granted on March 5, 2021. F4 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F6 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. F6 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 20:24 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionRestricted Stock Units · Derivative | 1,052 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-23-000011 · wf-form4_167822065494330.xml · derivative · entry 7 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,052 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2 · kind: Vesting of service-based restricted stock units granted on March 5, 2020. F4 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F5 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2021. F5 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2021. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 20:24 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 824 | $38.75 | $31,930.00 |
DisclosureSEC source: 0001585364-23-000011 · wf-form4_167822065494330.xml · nonDerivative · entry 6 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,983 Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 20:24 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionOrdinary Shares | 1,584 | $38.75 | $61,380.00 |
DisclosureSEC source: 0001585364-23-000011 · wf-form4_167822065494330.xml · nonDerivative · entry 5 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Vesting of service-based restricted stock units granted on March 5, 2021. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 20:24 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 548 | $38.75 | $21,235.00 |
DisclosureSEC source: 0001585364-23-000011 · wf-form4_167822065494330.xml · nonDerivative · entry 4 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,223 Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 20:24 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionOrdinary Shares | 1,052 | $38.75 | $40,765.00 |
DisclosureSEC source: 0001585364-23-000011 · wf-form4_167822065494330.xml · nonDerivative · entry 3 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Vesting of service-based restricted stock units granted on March 5, 2020. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 20:24 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 2,818 | $38.75 | $109,197.50 |
DisclosureSEC source: 0001585364-23-000011 · wf-form4_167822065494330.xml · nonDerivative · entry 2 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,719 Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 20:24 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantOrdinary Shares | 5,419 | $38.75 | $209,986.25 |
DisclosureSEC source: 0001585364-23-000011 · wf-form4_167822065494330.xml · nonDerivative · entry 1 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,537 F1 · kind: Vesting of performance-based restricted stock units granted on March 5, 2020. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 12:51 UTC | PERRIGO Co plc PRGO · Entity 4516 | SaleOrdinary Shares | 2,368 | $31.65 | $74,947.20 |
DisclosureSEC source: 0001585364-22-000100 · wf-form4_167154064728194.xml · nonDerivative · entry 1 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,118 Read SEC document |
| March 07, 2022 Filed Mar 8, 2022 21:55 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantRestricted Stock Units · Derivative | 6,748 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-22-000024 · wf-form4_164677651924029.xml · derivative · entry 12 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,748 Underlying: Ordinary Shares · 6,748 shares Expires not disclosed F5 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F5 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F9 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 7 March 2023. F9 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 7 March 2023. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:55 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionRestricted Stock Units · Derivative | 1,584 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-22-000024 · wf-form4_164677651924029.xml · derivative · entry 11 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,167 Underlying: Ordinary Shares · 1,584 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F4 · kind: Vesting of service-based restricted stock units granted on 5 March 2021. F5 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F8 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. F8 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:55 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionRestricted Stock Units · Derivative | 1,052 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-22-000024 · wf-form4_164677651924029.xml · derivative · entry 10 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,052 Underlying: Ordinary Shares · 1,052 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F3 · kind: Vesting of service-based restricted stock units granted on 5 March 2020. F5 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F7 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2021. F7 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2021. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:55 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionRestricted Stock Units · Derivative | 1,226 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-22-000024 · wf-form4_164677651924029.xml · derivative · entry 9 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,226 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2 · kind: Vesting of service-based restricted stock units granted on 6 March 2019. F5 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F6 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 6 March 2020. F6 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 6 March 2020. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:55 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 824 | $37.23 | $30,677.52 |
DisclosureSEC source: 0001585364-22-000024 · wf-form4_164677651924029.xml · nonDerivative · entry 8 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,486 Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:55 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionOrdinary Shares | 1,584 | $37.23 | $58,972.32 |
DisclosureSEC source: 0001585364-22-000024 · wf-form4_164677651924029.xml · nonDerivative · entry 7 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: Vesting of service-based restricted stock units granted on 5 March 2021. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:55 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 548 | $37.23 | $20,402.04 |
DisclosureSEC source: 0001585364-22-000024 · wf-form4_164677651924029.xml · nonDerivative · entry 6 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,726 Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:55 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionOrdinary Shares | 1,052 | $37.23 | $39,165.96 |
DisclosureSEC source: 0001585364-22-000024 · wf-form4_164677651924029.xml · nonDerivative · entry 5 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,274 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Vesting of service-based restricted stock units granted on 5 March 2020. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:55 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 638 | $37.23 | $23,752.74 |
DisclosureSEC source: 0001585364-22-000024 · wf-form4_164677651924029.xml · nonDerivative · entry 4 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,222 Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:55 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionOrdinary Shares | 1,226 | $37.23 | $45,643.98 |
DisclosureSEC source: 0001585364-22-000024 · wf-form4_164677651924029.xml · nonDerivative · entry 3 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,860 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Vesting of service-based restricted stock units granted on 6 March 2019. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:55 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 3,125 | $37.23 | $116,343.75 |
DisclosureSEC source: 0001585364-22-000024 · wf-form4_164677651924029.xml · nonDerivative · entry 2 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,634 Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:55 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantOrdinary Shares | 6,008 | $37.23 | $223,677.84 |
DisclosureSEC source: 0001585364-22-000024 · wf-form4_164677651924029.xml · nonDerivative · entry 1 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,759 F1 · kind: Vesting of performance-based restricted stock units granted on 6 March 2019. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 02:17 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 1,083 | $41.82 | $45,291.06 |
DisclosureSEC source: 0001585364-21-000027 · wf-form4_161534260400653.xml · nonDerivative · entry 2 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,658 Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 02:17 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantOrdinary Shares | 2,082 | $41.82 | $87,069.24 |
DisclosureSEC source: 0001585364-21-000027 · wf-form4_161534260400653.xml · nonDerivative · entry 1 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,741 F1 · kind: Vesting of performance-based restricted stock units granted on March 8, 2018. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:17 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantRestricted Stock Units · Derivative | 4,751 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-21-000027 · wf-form4_161534260400653.xml · derivative · entry 7 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,751 Underlying: Ordinary Shares · 4,751 shares Expires not disclosed F4 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F4 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F5 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. F5 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:17 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 548 | $41.04 | $22,489.92 |
DisclosureSEC source: 0001585364-21-000027 · wf-form4_161534260400653.xml · nonDerivative · entry 6 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,751 Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:17 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionOrdinary Shares | 1,053 | $41.04 | $43,215.12 |
DisclosureSEC source: 0001585364-21-000027 · wf-form4_161534260400653.xml · nonDerivative · entry 5 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Vesting of service-based restricted stock units granted on March 5, 2020. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:17 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 638 | $41.04 | $26,183.52 |
DisclosureSEC source: 0001585364-21-000027 · wf-form4_161534260400653.xml · nonDerivative · entry 4 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,246 Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:17 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionOrdinary Shares | 1,226 | $41.04 | $50,315.04 |
DisclosureSEC source: 0001585364-21-000027 · wf-form4_161534260400653.xml · nonDerivative · entry 3 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Vesting of service-based restricted stock units granted on March 6, 2019. Read SEC document |
| June 29, 2020 Filed Jul 1, 2020 17:59 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionRestricted Stock Units · Derivative | 262 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-20-000076 · wf-form4_159362637245139.xml · derivative · entry 3 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 262 shares Expires 2020-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F1 · kind: Vesting of service-based restricted stock units granted on June 29, 2015. F2 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Read SEC document |
| June 29, 2020 Filed Jul 1, 2020 17:59 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 137 | $54.56 | $7,474.72 |
DisclosureSEC source: 0001585364-20-000076 · wf-form4_159362637245139.xml · nonDerivative · entry 2 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,659 Read SEC document |
| June 29, 2020 Filed Jul 1, 2020 17:59 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionOrdinary Shares | 262 | $54.56 | $14,294.72 |
DisclosureSEC source: 0001585364-20-000076 · wf-form4_159362637245139.xml · nonDerivative · entry 1 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of service-based restricted stock units granted on June 29, 2015. Read SEC document |
| March 06, 2020 Filed Mar 11, 2020 00:51 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionRestricted Stock Units · Derivative | 1,227 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-20-000025 · wf-form4_158388787905764.xml · derivative · entry 7 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,227 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F3 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F4 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 6 March 2020. F4 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 6 March 2020. Read SEC document |
| March 06, 2020 Filed Mar 11, 2020 00:51 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 781 | $53.17 | $41,525.77 |
DisclosureSEC source: 0001585364-20-000025 · wf-form4_158388787905764.xml · nonDerivative · entry 6 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,534 Read SEC document |
| March 06, 2020 Filed Mar 11, 2020 00:51 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantOrdinary Shares | 1,501 | $53.17 | $79,808.17 |
DisclosureSEC source: 0001585364-20-000025 · wf-form4_158388787905764.xml · nonDerivative · entry 5 Quinn Grainne · CIK 0001679915 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,315 F2 · kind: Vesting of performance-based restricted stock units granted on June 6, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.